Stefania Morganti

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Stefania Morganti

Jan 12, 2025, 06:34 | Insight

Ilana Schlam: Great review led by Tess O’Meara on ADCs in breast cancer

A recent paper by Tess O’Meara, Hematology/Oncology Fellow at Dana-Farber Cancer Institute, was mentioned by…

Jan 10, 2025, 15:40 | Science

Tess O'Meara: Our review on antibody-drug conjugates in breast cancer

Tess O'Meara, Hematology/Oncology Fellow at Dana-Farber Cancer Institute, posted on X about recent paper by her…

Dec 11, 2024, 09:20 | Blog

Meet Dr. Stefania Morganti - Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: "Meet Dr. Stefania Morganti, an Advanced…

Oct 15, 2024, 11:55 | Insight

Overall survival with Pembrolizumab in early-stage TNBC - Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: "Check out this Practice Update commentary from…

Jun 30, 2024, 10:58 | Insight

Eleonora Nicolò: Our analysis on safety and efficacy of new drugs investigated in phase I/II clinical trials by age

Eleonora Nicolò, Research Fellow at Weill Cornell Medicine, shared a post on X: "Just out…

All: 5 Posts: 1 - 100

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023